SCHEDULE 13G/A: A.L. Sarroff Fund Discloses Significant Passive Stake in PetVivo Holdings, Inc.

Sentiment:

Beneficial Ownership Report 12 February 2025 3:26 PM

A.L. Sarroff Fund, LLC has reported a 27.96% passive beneficial ownership stake in PetVivo Holdings, Inc., holding 5,620,002 common shares.

Capital raiseA.L. Sarroff Fund, LLC holds 2,138,696 unexercised warrants of PetVivo Holdings, Inc. which, if exercised, would provide capital to the issuer.These warrants are exercisable on a schedule: 1,166,000 warrants as of August 4, 2026; 111,000 warrants as of December 6, 2026; 861,696 warrants as of April 29, 2027; and 2,500,000 warrants as of July 9, 2027.

Summary

A.L. Sarroff Fund, LLC filed an Amendment No. 8 to Schedule 13G regarding its beneficial ownership in PetVivo Holdings, Inc.
The fund beneficially owns 5,620,002 common shares of PetVivo Holdings, Inc., which represents 27.96% of the class.
This percentage is calculated based on 20,099,095 outstanding common shares of PetVivo Holdings, Inc. as of September 2024, according to the issuer's latest Form 10-Q.
A.L. Sarroff Fund, LLC also holds 2,138,696 unexercised warrants of the issuer, which are not included in the beneficial ownership calculation for this Schedule 13G filing, as per SEC Rule 13d-3(d)(1).
The filing is made under SEC Rule 13d-1(c), indicating that the securities were acquired and are held for passive investment purposes, without the intent to change or influence the control of the issuer.
A.L. Sarroff Fund, LLC is a New York Limited Liability Company.

Sentiment

Score: 7

Explanation: The disclosure of a significant passive beneficial ownership stake (27.96%) by A.L. Sarroff Fund, LLC in PetVivo Holdings, Inc. is generally a positive signal, indicating a substantial long-term investment by an institutional entity. The holding of additional warrants further reinforces this positive sentiment, suggesting potential future investment.

Positives

A significant institutional investor, A.L. Sarroff Fund, LLC, maintains a substantial passive stake of 27.96% in PetVivo Holdings, Inc., which can be interpreted as a vote of confidence in the company's long-term prospects.
The fund's holding of an additional 2,138,696 unexercised warrants represents potential future capital infusion for PetVivo Holdings, Inc. if these warrants are exercised.

Future Outlook

The document is a beneficial ownership report and does not provide forward-looking statements or guidance from PetVivo Holdings, Inc. regarding its future performance or strategic outlook. It only details the exercisability schedule of warrants held by the reporting person.

Management Comments

Alan L. Sarroff, Chief Executive Officer and Managing Member of A.L. Sarroff Fund, LLC, certified that the securities were not acquired and are not held for the purpose or with the effect of changing or influencing the control of the issuer, nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.

Industry Context

This filing indicates a significant passive investment by an institutional entity in PetVivo Holdings, Inc., a company likely operating in the animal health or biotechnology sector. Such a substantial stake, while passive, can be viewed as a positive signal of investor confidence in the company's long-term value proposition within its industry.

Stakeholder Impact

Shareholders: Provides transparency regarding a significant institutional shareholder's position, potentially boosting confidence due to a large, passive investment.
Management: Indicates the presence of a substantial, passive shareholder, which may influence strategic considerations without direct control.

Key Dates

Date	Description
September 2024	Date of the issuer's latest Form 10-Q, which reported 20,099,095 outstanding common shares.
February 5, 2025	Date of the event which required the filing of this statement.
February 12, 2025	Date of the Schedule 13G filing and signature by Alan L. Sarroff.
August 4, 2026	Date as of which 1,166,000 warrants become exercisable.
December 6, 2026	Date as of which 111,000 warrants become exercisable.
April 29, 2027	Date as of which 861,696 warrants become exercisable.
July 9, 2027	Date as of which 2,500,000 warrants become exercisable.

Keywords

PetVivo Holdings, A.L. Sarroff Fund, SEC filing, Schedule 13G, beneficial ownership, common stock, warrants, passive investment, institutional ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.